Cargando…
Infantile Hemangioma in a V2 Distribution: Treatment with Nadolol
Infantile hemangiomas are common benign tumours of infancy affecting up to 10% of children. They are typically not present at birth but undergo a rapid proliferation stage and then plateau in growth before resolving spontaneously. Recently, beta-blockers have been favoured over systemic corticostero...
Autores principales: | Giberson, Mariah, Hayes, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366987/ https://www.ncbi.nlm.nih.gov/pubmed/25811006 http://dx.doi.org/10.4103/2249-4863.152272 |
Ejemplares similares
-
Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial
por: Pope, Elena, et al.
Publicado: (2021) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Sclerotherapy for the Treatment of Infantile Hemangiomas
por: Grover, Chander, et al.
Publicado: (2012) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Incessant Automatic Atrial Tachycardia in a Neonate Successfully Treated with Nadolol and Closely Spaced Doses of Flecainide: A Case Report
por: Belli, Gilda, et al.
Publicado: (2020)